254 related articles for article (PubMed ID: 19440116)
1. Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients.
Ben M'rad M; Leclerc-Mercier S; Blanche P; Franck N; Rozenberg F; Fulla Y; Guesmi M; Rollot F; Dehoux M; Guillevin L; Moachon L
Medicine (Baltimore); 2009 May; 88(3):131-140. PubMed ID: 19440116
[TBL] [Abstract][Full Text] [Related]
2. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
3. Identification of thymus and activation-regulated chemokine (TARC/CCL17) as a potential marker for early indication of disease and prediction of disease activity in drug-induced hypersensitivity syndrome (DIHS)/drug rash with eosinophilia and systemic symptoms (DRESS).
Ogawa K; Morito H; Hasegawa A; Daikoku N; Miyagawa F; Okazaki A; Fukumoto T; Kobayashi N; Kasai T; Watanabe H; Sueki H; Iijima M; Tohyama M; Hashimoto K; Asada H
J Dermatol Sci; 2013 Jan; 69(1):38-43. PubMed ID: 23141052
[TBL] [Abstract][Full Text] [Related]
4. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
Hama N; Abe R; Gibson A; Phillips EJ
J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
[TBL] [Abstract][Full Text] [Related]
5. Treatment of DIHS/DRESS syndrome with combined N-acetylcysteine, prednisone and valganciclovir--a hypothesis.
Moling O; Tappeiner L; Piccin A; Pagani E; Rossi P; Rimenti G; Vedovelli C; Mian P
Med Sci Monit; 2012 Jul; 18(7):CS57-62. PubMed ID: 22739739
[TBL] [Abstract][Full Text] [Related]
6. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
Kano Y; Tohyama M; Aihara M; Matsukura S; Watanabe H; Sueki H; Iijima M; Morita E; Niihara H; Asada H; Kabashima K; Azukizawa H; Hashizume H; Nagao K; Takahashi H; Abe R; Sotozono C; Kurosawa M; Aoyama Y; Chu CY; Chung WH; Shiohara T
J Dermatol; 2015 Mar; 42(3):276-82. PubMed ID: 25623158
[TBL] [Abstract][Full Text] [Related]
7. DRESS/DiHS syndrome induced by Propylthiouracil: a case report.
Shen Q; Wang Q; Zang H; Yu L; Cong X; Chen X; Chen L
BMC Endocr Disord; 2023 Jan; 23(1):22. PubMed ID: 36691013
[TBL] [Abstract][Full Text] [Related]
8. Case report: Sulfasalazine-induced hypersensitivity.
Kuchinskaya EM; Chikova IA; Kostik MM
Front Med (Lausanne); 2023; 10():1140339. PubMed ID: 37293296
[TBL] [Abstract][Full Text] [Related]
9. Cicatrizing Conjunctivitis in a Patient Diagnosed With Drug Reaction With Eosinophilia and Systemic Symptoms/Drug-Induced Hypersensitivity Syndrome but With Features of Stevens-Johnson Syndrome.
Bohm KJ; Ciralsky JB; Harp JL; Bajaj S; Sippel KC
Cornea; 2016 Jun; 35(6):888-91. PubMed ID: 27078005
[TBL] [Abstract][Full Text] [Related]
10. Drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome: clinical features of 27 patients.
Avancini J; Maragno L; Santi CG; Criado PR
Clin Exp Dermatol; 2015 Dec; 40(8):851-9. PubMed ID: 26271788
[TBL] [Abstract][Full Text] [Related]
11. Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients.
Ang CC; Wang YS; Yoosuff EL; Tay YK
J Am Acad Dermatol; 2010 Aug; 63(2):219-27. PubMed ID: 20605253
[TBL] [Abstract][Full Text] [Related]
12. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts.
Criado PR; Criado RF; Avancini JM; Santi CG
An Bras Dermatol; 2012; 87(3):435-49. PubMed ID: 22714760
[TBL] [Abstract][Full Text] [Related]
13. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
Blumenthal KG; Patil SU; Long AA
Allergy Asthma Proc; 2012; 33(2):165-71. PubMed ID: 22525393
[TBL] [Abstract][Full Text] [Related]
14. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms due to lamotrigine differs from that due to other drugs.
Tashiro Y; Azukizawa H; Asada H; Niihara H; Morita E; Yamauchi T; Mizukawa Y; Kusakabe Y; Numazawa S; Izumi M; Sueki H; Watanabe H
J Dermatol; 2019 Mar; 46(3):226-233. PubMed ID: 30663091
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced hypersensitivity syndrome: drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome induced by aspirin treatment of Kawasaki disease.
Kawakami T; Fujita A; Takeuchi S; Muto S; Soma Y
J Am Acad Dermatol; 2009 Jan; 60(1):146-9. PubMed ID: 19103366
[TBL] [Abstract][Full Text] [Related]
16. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
Miyagawa F; Asada H
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670052
[TBL] [Abstract][Full Text] [Related]
17. Increased ratio of FoxP3+ regulatory T cells/CD3+ T cells in skin lesions in drug-induced hypersensitivity syndrome/drug rash with eosinophilia and systemic symptoms.
Morito H; Ogawa K; Fukumoto T; Kobayashi N; Morii T; Kasai T; Nonomura A; Kishimoto T; Asada H
Clin Exp Dermatol; 2014 Apr; 39(3):284-91. PubMed ID: 24635062
[TBL] [Abstract][Full Text] [Related]
18. Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management.
Shiohara T; Kano Y; Takahashi R; Ishida T; Mizukawa Y
Chem Immunol Allergy; 2012; 97():122-38. PubMed ID: 22613858
[TBL] [Abstract][Full Text] [Related]
19. Drug reaction with eosinophilia and systemic symptoms (DRESS): a complex interaction of drugs, viruses and the immune system.
Criado PR; Avancini J; Santi CG; Medrado AT; Rodrigues CE; de Carvalho JF
Isr Med Assoc J; 2012 Sep; 14(9):577-82. PubMed ID: 23101424
[TBL] [Abstract][Full Text] [Related]
20. [DRESS syndrome as a result of sulfasalazine use].
van der Mark SC; Segers D; Bakker RC; van Wijngaarden P
Ned Tijdschr Geneeskd; 2010; 154(18):A2161. PubMed ID: 23134745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
